Book Your Summer Shop Summer Reading
The Art of Process Chemistry
The refinement of a chemical process to the point where it becomes both cost and time efficient can be seen as "art." In a competitive environment where pharmaceutical companies are under ever increasing pressure to bring new drugs more quickly to the market, ways need to be found to provide bulk supplies of drug candidates as quickly as possible and to design manufacturing routes, which are robust, economical and environmentally firendly. This monograph is divided into 9 chapters, each one concentrating on a single class of drug candidates of chemistry development and describing the routes explored and the optimizations made to each drug candidate, inluding the discovery of applicable new chemistry and the elucidation of reaction mechanism.

From the contents:

  • Efairenz®, a Non-Nucleoside Reverse Transciptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate
  • CCR5 Receptor Antagonist
  • 5α-Reductase Inhibitors – The Finsteride Story
  • Rizatriptan (Maxalt®): A 5-HT1D Receptor Agonist
  • SERM: Selective Estrogen Receptor Modulator
  • HIV Integrase Inhibitor: Raltegravir
  • Cyclopentane-Based NK1 Receptor Antagonist
  • Glucokinase Activator
  • CB1R Inverse Agonist – Taranabant
"1100408509"
The Art of Process Chemistry
The refinement of a chemical process to the point where it becomes both cost and time efficient can be seen as "art." In a competitive environment where pharmaceutical companies are under ever increasing pressure to bring new drugs more quickly to the market, ways need to be found to provide bulk supplies of drug candidates as quickly as possible and to design manufacturing routes, which are robust, economical and environmentally firendly. This monograph is divided into 9 chapters, each one concentrating on a single class of drug candidates of chemistry development and describing the routes explored and the optimizations made to each drug candidate, inluding the discovery of applicable new chemistry and the elucidation of reaction mechanism.

From the contents:

  • Efairenz®, a Non-Nucleoside Reverse Transciptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate
  • CCR5 Receptor Antagonist
  • 5α-Reductase Inhibitors – The Finsteride Story
  • Rizatriptan (Maxalt®): A 5-HT1D Receptor Agonist
  • SERM: Selective Estrogen Receptor Modulator
  • HIV Integrase Inhibitor: Raltegravir
  • Cyclopentane-Based NK1 Receptor Antagonist
  • Glucokinase Activator
  • CB1R Inverse Agonist – Taranabant
148.0 In Stock
The Art of Process Chemistry

The Art of Process Chemistry

by Nobuyoshi Yasuda (Editor)
The Art of Process Chemistry
Add to Wishlist
The Art of Process Chemistry

The Art of Process Chemistry

by Nobuyoshi Yasuda (Editor)

Overview

The refinement of a chemical process to the point where it becomes both cost and time efficient can be seen as "art." In a competitive environment where pharmaceutical companies are under ever increasing pressure to bring new drugs more quickly to the market, ways need to be found to provide bulk supplies of drug candidates as quickly as possible and to design manufacturing routes, which are robust, economical and environmentally firendly. This monograph is divided into 9 chapters, each one concentrating on a single class of drug candidates of chemistry development and describing the routes explored and the optimizations made to each drug candidate, inluding the discovery of applicable new chemistry and the elucidation of reaction mechanism.

From the contents:

  • Efairenz®, a Non-Nucleoside Reverse Transciptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate
  • CCR5 Receptor Antagonist
  • 5α-Reductase Inhibitors – The Finsteride Story
  • Rizatriptan (Maxalt®): A 5-HT1D Receptor Agonist
  • SERM: Selective Estrogen Receptor Modulator
  • HIV Integrase Inhibitor: Raltegravir
  • Cyclopentane-Based NK1 Receptor Antagonist
  • Glucokinase Activator
  • CB1R Inverse Agonist – Taranabant

Product Details

ISBN-13: 9783527633586
Publisher: Wiley
Publication date: 12/01/2010
Sold by: JOHN WILEY & SONS
Format: eBook
Pages: 298
File size: 11 MB
Note: This product may take a few minutes to download.

About the Author

Nobuyoshi Yasuda received his bachelor from Tokyo Institute of Technology under the direction of Professor Teruaki Mukaiyama and Professor Hisashi Takei and his mater degree from the same university under the direction of Professor Hisashi Takei. After working at Fujisawa Pharmaceutical Company, Japan as a Medicinal Chemist, he received Ph. D. from Tokyo Institute of Technology in 1987. After spend one year as a postdoctoral fellow under Professor Robert M. Williams at Colorado State University from 1988 to 1989, he joined in Process Chemistry, Merck Research Laboratories in 1990. He has over 60 publications and over 50 patents.

Table of Contents

Preface

Efavirenz®, a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate

CCR5 Receptor Antagonist

5a-Reductase Inhibitors -
The Finasteride Story

Rizatriptan (Maxalt®): A 5-HT1D Receptor Agonist

SERM: Selective Estrogen Receptor Modulator

HIV Integrase Inhibitor: Raltegravir

Cyclopentane-Based NK1 Receptor Antagonist

Glucokinase Activator

CB1R Inverse Agonist -
Taranabant
From the B&N Reads Blog
Page 1 of

Related Subjects

Science & Technology
Chemistry
Technical & Industrial Chemistry
Science & Technology
Chemistry
Technical & Industrial Chemistry

Customer Reviews